Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An Author's Perspective
    • Ask the Experts
    • Bioanalysis articles
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Spotlights
    • Tech Digest
    • T&F journals

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Awareness
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Professional development
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

A new king of quantitation?

13 Nov 2019
General interest

Who will come out on top over four rounds of action? Including:

  • Method development
  • Maintenance
  • Sample analysis
  • Data management

Click here for a more in depth comparison

Click here to find out more about Drug Development Solutions Ltd


HRMS in DMPK banner

Top content

  • Sun Pharma strikes deal for $11.75bn acquisition of Organon
  • $1B deal for SiranBio’s oligonucleotide candidate
  • More human relevant models: how ACMs, multiomics and AI are helping change drug discovery

Related tags

analysis HRMS LGC quantitation Triple quadrupole
Previous article Next article

Related articles

10 APR 2014 DRUG DEVELOPMENT
A reflection on fit-for-purpose metabolite investigation at different stages of drug development
30 APR 2009 CHROMATOGRAPHY
Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography
30 JAN 2025 NEWS
Merck and Opentrons Labworks partner to create custom robotic workstation
11 OCT 2019 ASK THE EXPERTS
Ask the Experts: hybrid LBA/LC–MS
6 SEP 2016 GENERAL INTEREST
Protein quantitation workflows using the TripleTOF 6600: a case study for Rituximab (SCIEX)
2 MAR 2018 EXPERT OPINION
Ask the Experts: Bertrand Rochat
  • About
  • Accessibility
  • Advertising & Sponsorship
  • Contact Us
  • Editorial Policies
  • Permissions
  • Whitelist Emails
  • Zone Leaders

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone